# Memantine for Agitation and Aggression in Severe Alzheimer's Disease

> **NCT00401167** · PHASE4 · COMPLETED · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 31 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** memantine

## Key facts

- **NCT ID:** NCT00401167
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2024-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00401167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00401167, "Memantine for Agitation and Aggression in Severe Alzheimer's Disease". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT00401167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*